Paramount Communications Board Approves ₹122.63 Cr Share and Warrant Sale

Board Approves Fundraising Plan

Paramount Communications Ltd. announced that its Board of Directors has approved a preferential issue, aiming to raise around ₹122.63 crore. This fundraising involves issuing up to 21,997,664 equity shares and 7,200,000 warrants, with both shares and warrants priced at ₹42.00 each.

Funding Growth and Operations

This capital infusion is intended to support the company's growth. The funds could be used for expansion projects, paying down debt, or enhancing working capital. Investors should be aware of the potential dilution risk as warrants, once converted, will increase the total number of shares.

About Paramount Communications

Paramount Communications Ltd. is an Indian firm that manufactures power transmission cables, conductors, and specialty cables. The company is also engaged in infrastructure projects.

Impact of the Share Issue

The share issue aims to provide Paramount Communications with greater financial flexibility and funding for growth initiatives. However, it will lead to an increased share count, with a potential impact on earnings per share if the warrants are converted. The company will need shareholder approval at the upcoming EGM, and regulatory approvals could also affect the timing.

Key Risks to Monitor

Securing shareholder approval at the EGM on June 6, 2026, is essential for the issuance to proceed. The company also needs to obtain necessary regulatory clearances. The market's reaction to the terms of the fundraising and the potential dilution from warrant conversion are key factors that could influence the company's share price.

Industry Peers

Paramount Communications operates in India's cable and conductor manufacturing sector. Competitors such as Polycab India Ltd. and KEI Industries Ltd. have also recently invested heavily in expanding capacity and diversifying their product lines.

Next Steps for Investors

Investors will be watching the outcome of the EGM on June 6, 2026, for shareholder approval. Confirmation of required regulatory approvals and the timeline for completing the share and warrant issuance are also important. The company's strategy for using the new funds and the eventual conversion of warrants will be key points to track.